Literature DB >> 22350562

A case control study of the implementation of change model versus passive dissemination of practice guidelines for compliance in monitoring for metabolic syndrome.

Dawn I Velligan1, Desiree Castillo, Linda Lopez, Bren Manaugh, Charlotte Davis, Juanita Rodriguez, A Camis Milam, Albana Dassori, Alexander L Miller.   

Abstract

We developed an intervention to improve compliance with guidelines for monitoring metabolic syndrome and compared compliance prior to intervention and three times post-intervention at three community mental health clinics in Texas. One test clinic received intervention and two other clinics served as controls. Fifty random charts were reviewed from each clinic for three specific, 1-2 weeks periods over the course of 18 months. There were significant improvements in the ordering of labs, the presence of lab results in the chart, and documentation of blood pressure, body mass index and waist circumference in the intervention clinic over time in comparison to the control clinics. Documented evidence of physician action with respect to out of range values remained low. Metabolic monitoring is a multi-step process. Removing barriers, creating specific procedures, and dedicating staff resources can improve compliance with monitoring.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350562     DOI: 10.1007/s10597-011-9472-z

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  16 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls.

Authors:  Donald C Goff; Lisa M Sullivan; Joseph P McEvoy; Jonathan M Meyer; Henry A Nasrallah; Gail L Daumit; Steven Lamberti; Ralph B D'Agostino; Thomas S Stroup; Sonia Davis; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2005-09-28       Impact factor: 4.939

4.  Translating venous thromboembolism (VTE) prevention evidence into practice: a multidisciplinary evidence implementation project.

Authors:  Jed Duff; Kim Walker; Abdullah Omari
Journal:  Worldviews Evid Based Nurs       Date:  2010-12-13       Impact factor: 2.931

Review 5.  Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

Review 6.  Excess mortality of mental disorder.

Authors:  E C Harris; B Barraclough
Journal:  Br J Psychiatry       Date:  1998-07       Impact factor: 9.319

Review 7.  Physical health monitoring of patients with schizophrenia.

Authors:  Stephen R Marder; Susan M Essock; Alexander L Miller; Robert W Buchanan; Daniel E Casey; John M Davis; John M Kane; Jeffrey A Lieberman; Nina R Schooler; Nancy Covell; Scott Stroup; Ellen M Weissman; Donna A Wirshing; Catherine S Hall; Leonard Pogach; Xavier Pi-Sunyer; J Thomas Bigger; Alan Friedman; David Kleinberg; Steven J Yevich; Bonnie Davis; Steven Shon
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

Review 8.  Antipsychotic medications: metabolic and cardiovascular risk.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

9.  Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.

Authors:  Elaine H Morrato; John W Newcomer; Siddhesh Kamat; Onur Baser; James Harnett; Brian Cuffel
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

10.  Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

Authors:  Craig W Colton; Ronald W Manderscheid
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

View more
  3 in total

1.  Antipsychotic Cardiometabolic Side Effect Monitoring in a State Community Mental Health System.

Authors:  Robert O Cotes; Alex de Nesnera; Michael Kelly; Karen Orsini; Haiyi Xie; Greg McHugo; Stephen Bartels; Mary F Brunette
Journal:  Community Ment Health J       Date:  2015-02-03

2.  A Randomized Controlled Trial of a Patient-Centered Approach to Improve Screening for the Metabolic Side Effects of Antipsychotic Medications.

Authors:  Julie Kreyenbuhl; Lisa B Dixon; Clayton H Brown; Deborah R Medoff; Elizabeth A Klingaman; Li Juan Fang; Stephanie Tapscott; Mary Brighid Walsh
Journal:  Community Ment Health J       Date:  2016-04-09

3.  Utilization of the Behavior Change Wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness.

Authors:  Christina Mangurian; Grace C Niu; Dean Schillinger; John W Newcomer; James Dilley; Margaret A Handley
Journal:  Implement Sci       Date:  2017-11-14       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.